Associated Papers
Novel engineered nanobodies specific for N-terminal region of alpha-synuclein recognize Lewy-body pathology and inhibit in-vitro seeded aggregation and toxicity.
Hmila I et al.
The Febs Journal, 2022
Differences in the binding of copper(I) to α- and β-synuclein.
De Ricco R et al.
Inorganic Chemistry, 2015
Select a paper to view details